Patents by Inventor Myra N. Widjojoatmodjo

Myra N. Widjojoatmodjo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150320854
    Abstract: Described is a vaccine against respiratory syncytial virus (RSV), comprising a recombinant human adenovirus of serotype that comprises polynucleotide encoding a RSV F protein or immunologically active part thereof.
    Type: Application
    Filed: May 26, 2015
    Publication date: November 12, 2015
    Inventors: Katarina Radosevic, Jerome H.H.V. Custers, Jort Vellinga, Myra N. Widjojoatmodjo
  • Patent number: 9125870
    Abstract: Provided is a vaccine against respiratory syncytial virus (RSV), comprising a recombinant human adenovirus of serotype 26 that comprises nucleic acid encoding a RSV F protein or immunologically active part thereof.
    Type: Grant
    Filed: March 22, 2013
    Date of Patent: September 8, 2015
    Assignee: Crucell Holland B.V.
    Inventors: Katarina Radosevic, Jerome H. H. V. Custers, Jort Vellinga, Myra N. Widjojoatmodjo
  • Patent number: 9119813
    Abstract: Provided is a vaccine against respiratory syncytial virus (RSV), comprising a recombinant human adenovirus of serotype that comprises nucleic acid encoding a RSV F protein or immunologically active part thereof.
    Type: Grant
    Filed: March 22, 2013
    Date of Patent: September 1, 2015
    Assignee: Crucell Holland B.V.
    Inventors: Katarina Radosevic, Jerome H. H. V. Custers, Jort Vellinga, Myra N. Widjojoatmodjo
  • Publication number: 20150196632
    Abstract: Provided is a vaccine against respiratory syncytial virus (RSV), comprising a recombinant human adenovirus of serotype 26 that comprises nucleic acid molecule encoding a RSV F protein or immunologically active part thereof.
    Type: Application
    Filed: March 31, 2015
    Publication date: July 16, 2015
    Inventors: Katarina Radosevic, Jerome H. Custers, Jort Vellinga, Myra N. Widjojoatmodjo
  • Publication number: 20140186391
    Abstract: Provided is a vaccine against respiratory syncytial virus (RSV), comprising a recombinant human adenovirus of serotype that comprises nucleic acid encoding a RSV F protein or immunologically active part thereof.
    Type: Application
    Filed: March 22, 2013
    Publication date: July 3, 2014
    Applicant: CRUCELL HOLLAND B.V.
    Inventors: KATARINA RADOSEVIC, JEROME H. H. V. CUSTERS, JORT VELLINGA, MYRA N. WIDJOJOATMODJO
  • Publication number: 20140147463
    Abstract: Provided is a vaccine against respiratory syncytial virus (RSV), comprising a recombinant human adenovirus of serotype 26 that comprises nucleic acid encoding a RSV F protein or immunologically active part thereof.
    Type: Application
    Filed: March 22, 2013
    Publication date: May 29, 2014
    Applicant: CRUCELL HOLLAND B.V.
    Inventors: KATARINA RADOSEVIC, JEROME H. H. V. CUSTERS, JORT VELLINGA, MYRA N. WIDJOJOATMODJO
  • Patent number: 6923969
    Abstract: The invention relates to vaccines used in the eradication or control of pestivirus infections, particularly used in pigs or ruminants. The invention provides nucleic acid, pestivirus-like particles and a pestivirus vaccine, comprising the nucleic acid or particles, which is capable of eliciting a proper immune response without having the ability to spread throughout the vaccinated animal, thereby avoiding the negative consequences of viral spread. Preferably, the immunological response allows for serological discrimination between vaccinated animals and wild-type pestivirus infected animals.
    Type: Grant
    Filed: September 7, 2001
    Date of Patent: August 2, 2005
    Assignee: ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V.
    Inventors: Myra N. Widjojoatmodjo, Robertus Jacobus Maria Moormann, Petrus Antonius Van Rijn